555 news items
Page 9 of 28
ycviyx63xk0 jb
16 Apr 24
researchers to rapidly obtain high-quality data to advance their vaccines and therapeutic antibodies
5s7bp
CVAC
16 Apr 24
and clinical research expertiseCollaboration aims to develop novel, off-the-shelf, mRNA-based cancer vaccines in selected
pecnabc43y 1ffbyrtefoc374nb
16 Apr 24
cancer with limited treatment options so far. The clinical development of zongertinib was accelerated, based upon positive early clinical data
1uuun691wr8r4oah76a3r74gd451z457ffvg2q3u6
15 Apr 24
CD19 to treat blood cancers. Our pipeline also includes multiple immunotherapy B-cell vaccine candidates and an oncolytic virotherapy (CF33) aimed
6084qb0piy6 wlr4n2llrbawpcscfeg1b
15 Apr 24
and on-site cancer screenings
is7lnoe722p6h1zdm7ns41t30hzgnilfe75nelsgvyv3a7o5whhz5e
15 Apr 24
Disease Burden: The rising incidence of chronic diseases such as diabetes and cancer is driving the need for wearable injectors. Healthcare
at0ol
PFE
15 Apr 24
of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar
v9llxl lxplyxq5
IOBT
15 Apr 24
biopharmaceutical company developing novel, immune-modulating therapeutic cancer vaccines based on its T-win® platform, today announced that Marjan
7dfdorsserpyo2vzkyyxutkib6xsuu wqgzux
SNGX
15 Apr 24
MarVax™ Heat Stable Vaccine Seven Years of U.S. Market
lmqyeuuc2
NVAX
15 Apr 24
and believes that, despite the issues outlined above, its Matrix-M adjuvant vaccine franchise has an extremely bright future. This potential is well
u4jyxy9
GRTS
12 Apr 24
personalized cancer vaccine candidate Granite, including a short-term response analysis that did not demonstrate a difference between study arms
y2utczl2qamkz3w8kxhj6g9
VBIV
11 Apr 24
VBI Vaccines Inc. (NASDAQ:VBIV) (VBI